Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11222711 Predicting immunogenicity of T cell epitopes

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
May 7, 2014
0
Date of Patent
January 11, 2022
0
Patent Application Number
14787110
0
Patent Citations Received
‌
US Patent 12091443 Method of compact peptide vaccines using residue optimization
0
‌
US Patent 11464842 Compositions and method for optimized peptide vaccines using residue optimization
‌
US Patent 11672850 Compositions and method for optimized peptide vaccines using residue optimization
0
‌
US Patent 11673936 Method of compact peptide vaccines using residue optimization
0
‌
US Patent 12064475 Compositions and method for optimized peptide vaccines using residue optimization
0
‌
US Patent 11464837 Immunogenic compositions comprising nucleic acids for RAS peptides
Patent Inventor Names
Ugur Sahin
0
Arbel David Tadmor
0
John Christopher Castle
0
Martin Löwer
0
Sebastian Boegel
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11222711
0
Patent Primary Examiner
‌
Michael L Borin
0

Find more entities like US Patent 11222711 Predicting immunogenicity of T cell epitopes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo